Gsa Capital Partners LLP Bio Xcel Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$9.03 - $21.55 $239,602 - $571,807
26,534 New
26,534 $350,000
Q4 2021

Feb 14, 2022
SELL
$20.12 - $35.09 $1.19 Million - $2.08 Million
-59,344 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$23.84 - $32.03 $1.41 Million - $1.9 Million
59,344 New
59,344 $1.8 Million

Others Institutions Holding BTAI

# of Institutions
51
Shares Held
3.11M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $7.85M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email